A carregar...

Prodigiosin rescues deficient p53 signaling and anti-tumor effects via up-regulating p73 and disrupting its interaction with mutant p53

p53 reactivation offers a broad-based strategy for cancer therapy. In this study we report the identification of prodigiosin that can reactivate p53 family-dependent transcriptional activity in p53 deficient human colon cancer cells. Prodigiosin and its structural analogue (compound R) induced the e...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res
Main Authors: Hong, Bo, Prabhu, Varun V., Zhang, Shengliang, van den Heuvel, A. Pieter J., Dicker, David T., Kopelovich, Levy, El-Deiry, Wafik S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4535712/
https://ncbi.nlm.nih.gov/pubmed/24247721
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-13-0955
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!